Relevate Health Group and Arteric Appoint Three New Members
to Board of Directors
Cincinnati, OH, March 29, 2021 – Relevate Health Group and Arteric, leaders in local and national Healthcare Provider marketing via machine learning and data, appoints three new members to its Board of Directors.
Michael Darviche, Cynthia Schwalm and Christopher French have joined the Board of Directors to assist senior leadership with developing strategies for future expansion and growth.
“We are thrilled to have Mike, Cynthia and Chris join our Board. Their extensive knowledge of the healthcare industry and expertise in business consulting will be vital to the development of our strategic growth plan. This group has a strong track record of building businesses, especially ones that leverage data, technologies and digital. They bring invaluable experience for executing our strategic growth plan”, said Jeff Spanbauer, Chief Executive Officer of Relevate Health Group.
Darviche is a long-time technology, digital and data executive who has led company transformations for Marsh Inc and Acxiom. He has served as CEO, GM, Chief Marketing, Chief Strategy and Chief Digital Officer for VC backed and public companies. Today his firm, Bridge22, builds and leads organic and inorganic growth programs for high growth companies in product, marketing and M&A.
Schwalm is a senior life sciences executive with decades of strategic and operational leadership experience developing and expanding healthcare organizations in the pharmaceutical, start-up and bio-tech industries. Schwalm held senior leadership positions at Johnson & Johnson, Amgen, Eisai and Ipsen, and received numerous leadership awards and recognitions.
French is a seasoned healthcare executive and corporate development professional with more than 30 years of experience in successful M&A transactions. In addition to his M&A expertise, French held senior leadership positions at two highly successful healthcare technology businesses and has twenty-five years of Board of Directors experience across three private equity-backed companies.
Darviche stated, “I am a big fan of what Relevate and Arteric have built, and I see their many opportunities in healthcare marketing accelerating as we come out of Covid-19 in 2021 and beyond. I am excited for the opportunity to work with this dynamic team to help innovate and support their growth. Relevate has a very powerful suite of local content products powered by Arteric’s machine learning and data science and their own platform technology investment. Their multichannel digital marketing agency extends this to national campaigns as well. I see so many ways to expand on these assets today.”
Schwalm stated “Relevate and Arteric have the capability to facilitate increased delivery of relevant communications between health care providers, their networked communities and patients. I look forward to working with the board and leadership team”.
French added, “I am very excited to work with the leadership of Relevate and Arteric and other Board members. I look forward to working with this talented group to develop strategies to propel them into future expansion.”
Relevate Health Group completed a strategic combination with Arteric is December 2020. This strategic combination forms a next generation data & ML-driven agency serving the pharmaceutical, biotechnology and healthcare markets. The combined company is capitalizing on its shared expertise to provide a full range of digital marketing services for leading, challenger and new growth brands.
* * * *
Relevate Health Group is an MM&M top 100 Agency focused on data-driven local marketing products and services for healthcare clients. Learn more at www.relevatehealthgroup.com.
Arteric is an MM&M top 100 Agency, with 41 design & UX awards, recognized by Gartner for
ML and named to MM&M’s list of Best Places to work. Learn more at www.arteric.com.
For more information, please contact us.